Pengzhao Shang, Rui Gao, Yijia Zhu, Xiaorui Zhang, Yang Wang, Minji Guo, Hui Peng, Min Wang, Juan Zhang. Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ Acta Pharm Sin B 11 (2021) 420–433J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2790-2790. DOI: 10.1016/j.apsb.2024.02.014
|
Citation:
|
Pengzhao Shang, Rui Gao, Yijia Zhu, Xiaorui Zhang, Yang Wang, Minji Guo, Hui Peng, Min Wang, Juan Zhang. Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ Acta Pharm Sin B 11 (2021) 420–433J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2790-2790. DOI: 10.1016/j.apsb.2024.02.014
|
Pengzhao Shang, Rui Gao, Yijia Zhu, Xiaorui Zhang, Yang Wang, Minji Guo, Hui Peng, Min Wang, Juan Zhang. Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ Acta Pharm Sin B 11 (2021) 420–433J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2790-2790. DOI: 10.1016/j.apsb.2024.02.014
|
Citation:
|
Pengzhao Shang, Rui Gao, Yijia Zhu, Xiaorui Zhang, Yang Wang, Minji Guo, Hui Peng, Min Wang, Juan Zhang. Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ Acta Pharm Sin B 11 (2021) 420–433J. Acta Pharmaceutica Sinica B, 2024, 14(6): 2790-2790. DOI: 10.1016/j.apsb.2024.02.014
|